Figure 4 from: Alvarado AT, Muñoz AM, Varela N, Sullón-Dextre L, Pineda M, Bolarte-Arteaga M, Bendezú MR, García JA, Chávez H, Surco-Laos F, Melgar-Merino EJ, Cuba-Garcia PA, Molina-Cabrera A, Pari-Olarte B, Bonifaz-Hernandez M, Panay-Centeno JF, Kong-Chirinos J, Almeida-Galindo J (2023) Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru. Pharmacia 70(3): 603-618. https://doi.org/10.3897/pharmacia.70.e109011